Evidence map›Paper›PMID 41688461›Full record

ArticleNature communications2026

Expression of nano-engineered RNA organelles in bacteria.

Brian Ng, Catherine Fan, Milan Dordevic, Adam Knirsch, Layla Malouf, Giacomo Fabrini, Sabrina Pia Nuccio, Roger Rubio-Sánchez, Graham Christie, Masahiro Takinoue and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brian Ng *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6306-5539
Catherine Fan *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Milan Dordevic *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Adam Knirsch *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0009-0007-5703-0218
Layla MaloufDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0009-0008-5358-3306
Giacomo FabriniDepartment of Chemistry, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-8601-1680
Sabrina Pia NuccioDepartment of Chemistry, Imperial College London, London, UK.
Roger Rubio-SánchezDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-5574-5809
Graham ChristieDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Masahiro TakinoueLaboratory for Chemistry and Life Science, Institute of Integrated Research (IIR), Institute of Science Tokyo, Tokyo, Japan.
Pietro CicutaCavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9193-8496
Lorenzo Di MicheleDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. ld389@cam.ac.uk.ORCID http://orcid.org/0000-0002-1458-9747

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 851667MEXT | Japan Science and Technology Agency (JST) JPMJAP24B4MEXT | Japan Society for the Promotion of Science (JSPS) JP24H00070, JP25H01361RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X010228/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X012557/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S023518/1Royal Society URF\R\221009
6 · The paper itself

Abstract

Designing synthetic biomolecular condensates, or membraneless organelles, offers insights into the functions of their natural counterparts and is equally valuable for cellular and metabolic engineering. Choosing E. coli for its biotechnological relevance, we deploy RNA nanotechnology to design and express non-natural membraneless organelles in vivo. The designer condensates assemble co-transcriptionally from branched RNA motifs interacting via base-pairing. Exploiting binding selectivity, we express orthogonal, non-mixing condensates, and by embedding a protein-binding aptamer, we achieve selective protein recruitment. Condensates can be made to dissolve and reassemble upon thermal cycling, thereby reversibly releasing and re-capturing protein clients. The synthetic organelles are expressed robustly across the cell population and remain stable despite enzymatic RNA processing. Compared with existing solutions based on peptide building blocks or repetitive RNA sequences, these nanostructured RNA motifs enable algorithmic control over interactions, affinity for clients, and condensate microstructure, opening further directions in synthetic biology and biotechnology.

Indexed as

Escherichia coliNanotechnologyOrganellesRNAAptamers, NucleotideBiomolecular CondensatesNanostructuresSynthetic BiologyAptamers, NucleotideRNA

Identifiers

PMID41688461
PMCPMC13018614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.